On Chemball
My Chemball
+86-571-8627 3270
Jiangsu Nhwa Pharmaceutical Co., LTD
Jiangsu Nhwa Pharmaceutical Co., LTD
46 YRS
Jiangsu, China
Main Products:
Buspirone Hydrochloride / Lithium Carbonate / Penfluridol / 1-{2-[(2,4-Dichlorobenzyl)Oxy]-2-(2,4-Dichlorophenyl)Ethyl}-1H-Imidazole / Econazole Nitrate / 1-[Phenyl-(4-Phenylphenyl)Methyl]Imidazole / Fenofibrate
Jiangsu, China
Send Email
Sending...
Thank You！
Your requirement has been sent, we will contact you quickly!
Sent Failed！
Try again!
ABOUT US
Jiangsu Enhua Pharmaceutical Co., Ltd., founded in 1978 and listed on Shenzhen Stock Exchange in 2008 with stock code 002262, is a pharmaceutical enterprise integrating science, industry and trade, a national designated manufacturer of psychotropic drugs, a national high-tech enterprise, a national top 100 pharmaceutical enterprises, a national technological innovation demonstration enterprise and a national intellectual property demonstration unit, The star unit of the national "20 years and 20 stars" pharmaceutical quality management enterprise, the enterprise confirmed by the international environmental certification (ISO14000), the first batch of innovative enterprises in Jiangsu Province, the vice president unit of China narcotic drugs Association and the vice president unit of Jiangsu Pharmaceutical Industry Association.
The company mainly produces and operates central nervous system drugs, strategically positioned in the market of central nervous system drugs, and is mainly engaged in the development, production and sales of central nervous system drugs. It is an enterprise focusing on the subdivided market of central nervous system drugs, mainly including anesthesia, psychosis and neurology. Through years of unremitting efforts in product R & D, production and service, The company has established a complete product series and marketing network of central nervous system drugs, and strive to build an important manufacturer and distributor of central nervous system drugs in China. In addition, the company has a series of cardiovascular and cerebrovascular products in different R & D stages, with brand-new chemical structure and action mechanism, and gradually intervene in the cardiovascular and cerebrovascular drug market with broad market prospects.
Basic Information
Tax ID
913203001363846728
Country/Region
Jiangsu, China
Year Established
1978
Registered Capital
CNY 1080 Million
Business Type
Manufacturer
Total Employees
Over 1000 people
Quality Management Certificate
-
Total Annual Revenue
CNY 123 Million
Enterprise Ownership
Private Owned
Is This Your Own Factory
Yes
Summary Up
It is an enterprise focusing on the market segment of central nervous drugs
PLANT LOCATION
COMPANY ALBUM
